Alfonso
Cordero Barreal
![Foto de Alfonso](/img/nophoto.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2024
-
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy
Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1
2020
-
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis
The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 11
-
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing
International Journal of Cancer, Vol. 146, Núm. 2, pp. 521-530